News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
684,878 Results
Type
Article (39035)
Company Profile (280)
Press Release (645563)
Section
Business (203927)
Career Advice (1987)
Deals (35369)
Drug Delivery (85)
Drug Development (80864)
Employer Resources (168)
FDA (16087)
Job Trends (14802)
News (344664)
Policy (32442)
Tag
Academia (2533)
Alliances (49092)
Alzheimer's disease (1221)
Approvals (16010)
Artificial intelligence (124)
Bankruptcy (352)
Best Places to Work (11516)
Biotechnology (201)
Breast cancer (115)
Cancer (1019)
Cardiovascular disease (84)
Career advice (1657)
Cell therapy (214)
Clinical research (64136)
Collaboration (357)
Compensation (185)
COVID-19 (2525)
C-suite (86)
Data (1000)
Diabetes (148)
Diagnostics (6122)
Earnings (84665)
Employer resources (146)
Events (109312)
Executive appointments (273)
FDA (16576)
Funding (319)
Gene therapy (163)
GLP-1 (571)
Government (4322)
Healthcare (18665)
Infectious disease (2606)
Inflammatory bowel disease (104)
Interviews (308)
IPO (16283)
Job creations (3623)
Job search strategy (1415)
Layoffs (411)
Legal (7853)
Lung cancer (160)
Manufacturing (165)
Medical device (13163)
Medtech (13168)
Mergers & acquisitions (19132)
Metabolic disorders (389)
Neuroscience (1475)
NextGen Class of 2024 (6498)
Non-profit (4466)
Northern California (1372)
Obesity (227)
Opinion (178)
Patents (97)
People (56214)
Phase I (19928)
Phase II (28239)
Phase III (21065)
Pipeline (370)
Postmarket research (2553)
Preclinical (8475)
Radiopharmaceuticals (234)
Rare diseases (198)
Real estate (5888)
Regulatory (21486)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1217)
Startups (3562)
United States (12705)
Vaccines (547)
Weight loss (166)
Date
Today (227)
Last 7 days (1007)
Last 30 days (3533)
Last 365 days (35394)
2024 (31715)
2023 (40087)
2022 (51196)
2021 (55734)
2020 (54099)
2019 (46554)
2018 (35034)
2017 (32132)
2016 (31510)
2015 (37574)
2014 (31339)
2013 (26354)
2012 (28579)
2011 (29272)
2010 (27330)
Location
Africa (713)
Arizona (190)
Asia (37098)
Australia (6072)
California (3077)
Canada (1232)
China (235)
Colorado (132)
Connecticut (140)
Europe (79479)
Florida (426)
Georgia (109)
Illinois (330)
Indiana (189)
Kansas (96)
Maryland (557)
Massachusetts (2464)
Michigan (151)
Minnesota (263)
New Jersey (896)
New York (906)
North Carolina (681)
Northern California (1372)
Ohio (132)
Pennsylvania (801)
South America (1091)
Southern California (1217)
Texas (423)
Utah (86)
Washington State (343)
684,878 Results for "immunotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
OSE Immunotherapeutics Provides Business and Corporate Update
OSE Immunotherapeutics Provides Business and Corporate Update Three pharmaceutical agreements signed during the last three months.
May 30, 2024
·
12 min read
Press Releases
Matica Biotechnology Establishes CDMO Partnership with KaliVir Immunotherapeutics
October 25, 2024
·
3 min read
Press Releases
KaliVir Immunotherapeutics Announces FDA Clearance of Investigational New Drug (IND) for Oncolytic Immunotherapy VET3-TGI for Solid Tumors
KaliVir Immunotherapeutics, Inc. today announced that the FDA has cleared the Investigational New Drug (IND) application for the STEALTH-001 study of VET3-TGI in patients with incurable, advanced solid tumors.
July 1, 2024
·
2 min read
Press Releases
Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates
November 6, 2024
·
8 min read
Press Releases
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in Acute Lymphoblastic Leukemia in the Journal ‘Blood’
July 1, 2024
·
9 min read
Business
OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell Therapies
OSE Immunotherapeutics SA, announced that the Company has entered into a commercial and revenue sharing agreement with leading global cancer center.
June 24, 2024
·
6 min read
Business
OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the Board of Directors Ready to Drive the Strategic Company’s Growth
OSE Immunotherapeutics SA announced that all the resolutions submitted to a vote at the Combined General Shareholders’ Meeting were approved as proposed by OSE Immunotherapeutics’ Board of Directors.
June 19, 2024
·
15 min read
Press Releases
KaliVir Immunotherapeutics Doses First Patient in Phase 1/1b Trial of VET3-TGI for Incurable, Advanced, Solid Tumors
October 8, 2024
·
3 min read
Press Releases
MoonLake Immunotherapeutics Reports Third Quarter 2024 Financial Results and Provides a Business Update
November 7, 2024
·
18 min read
Business
OSE Immunotherapeutics and Boehringer Ingelheim expand collaboration to develop first-in-class treatments for cancer and cardio-renal-metabolic diseases
OSE Immunotherapeutics SA and Boehringer Ingelheim announced a major expansion of their partnership.
May 22, 2024
·
9 min read
1 of 68,488
Next
